SNSE - Sensei Biotherapeutics to Participate in Upcoming Investor Conferences | Benzinga

BOSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that Company management will participate in the following investor conferences in September 2023:

Citi's 18^th Annual Biopharma Conference
September 5^th-7^th
Boston, MA

Wells Fargo's 2023 Healthcare Conference
September 5^th-8^th
Boston, MA

Portfolio managers and analysts who would like to request a meeting with management should contact their representative at the respective ...

Full story available on Benzinga.com